Dr. Douglas Alan Brylka

Radiology NPI1114181963

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$249.65
from 7 payments in the last 6 years

Total Cash or Cash Equivalent

$208.01
from 4 payments in the last 6 years

Total In-kind Items & Services

$41.64
from 3 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/11/2019 General (Non-Research) In-kind items and services Food and Beverage $13.25 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695732887
08/07/2019 General (Non-Research) In-kind items and services Food and Beverage $14.01 Details
Payment from Regeneron Healthcare Solutions, Inc.
Payment Record ID 673352899
12/13/2019 General (Non-Research) In-kind items and services Food and Beverage $14.38 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Payment Record ID 628433359
05/11/2016 Research Cash or cash equivalent $33.12 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Paymment Research Study Phase II MCL post Ibrutinib
Payment Record ID 420750205
05/11/2016 Research Cash or cash equivalent $42.40 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Paymment Research Study Phase II MCL post Ibrutinib
Payment Record ID 420750193
05/11/2016 Research Cash or cash equivalent $59.62 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Paymment Research Study Phase II MCL post Ibrutinib
Payment Record ID 420750135
05/11/2016 Research Cash or cash equivalent $72.87 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Paymment Research Study Phase II MCL post Ibrutinib
Payment Record ID 420750095